newsfilter
← Latest News
GlobeNewswire·

Can-Fite Secures Japanese Patent Allowance for Namodenoson's Anti-Obesity Technology

The allowed Patent strengthens protection in one of the world's largest pharmaceutical markets and further supports Namodenoson's positioning in obesity and metabolic diseases Ramat Gan, Israel, June 26, 2026